Nanjing Pharmaceutical Factory is a privately-owned enterprise based in China, specializing in the production and distribution of pharmaceutical goods.
[Translation] A human bioequivalence clinical trial of imidacin tablets (0.1 mg) in Chinese healthy subjects after single administration in fasting and fed state
1. Using imidafenacin tablets (0.1 mg, trade name Uritos) produced by Kyorin Pharmaceutical Co., Ltd. as the reference preparation and imidafenacin tablets (0.1 mg) produced by Nanjing Pharmaceutical Factory Co., Ltd. as the test preparation, a single-center, randomized, open, single-dose, two-preparation, two-cycle, two-sequence, crossover clinical trial was conducted to evaluate the bioequivalence of the two preparations in fasting and fed states in healthy Chinese subjects.
2. Observe the safety of the test preparation and the reference preparation in healthy Chinese subjects.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.